SK43699A3 - Process for preparing hydroxamic acids - Google Patents

Process for preparing hydroxamic acids Download PDF

Info

Publication number
SK43699A3
SK43699A3 SK436-99A SK43699A SK43699A3 SK 43699 A3 SK43699 A3 SK 43699A3 SK 43699 A SK43699 A SK 43699A SK 43699 A3 SK43699 A3 SK 43699A3
Authority
SK
Slovakia
Prior art keywords
carbon atoms
heteroaryl
aryl
alkyl
moiety
Prior art date
Application number
SK436-99A
Other languages
English (en)
Slovak (sk)
Inventor
Joel M Hawkins
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SK43699A3 publication Critical patent/SK43699A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
SK436-99A 1998-04-10 1999-04-01 Process for preparing hydroxamic acids SK43699A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
SK43699A3 true SK43699A3 (en) 2000-06-12

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
SK436-99A SK43699A3 (en) 1998-04-10 1999-04-01 Process for preparing hydroxamic acids

Country Status (38)

Country Link
US (1) US6288246B1 (xx)
EP (1) EP0949244A3 (xx)
JP (1) JPH11343277A (xx)
KR (1) KR100329902B1 (xx)
CN (1) CN1232023A (xx)
AP (1) AP1203A (xx)
AR (1) AR018180A1 (xx)
AU (1) AU747629B2 (xx)
BG (1) BG64154B1 (xx)
BR (1) BR9901089A (xx)
CA (1) CA2268680A1 (xx)
CO (1) CO5070713A1 (xx)
DZ (1) DZ2757A1 (xx)
EA (1) EA002777B1 (xx)
EG (1) EG22263A (xx)
GT (1) GT199900046A (xx)
HR (1) HRP990105A2 (xx)
HU (1) HUP9901041A3 (xx)
ID (1) ID23337A (xx)
IL (1) IL129328A0 (xx)
IN (1) IN192342B (xx)
IS (1) IS5019A (xx)
MA (1) MA24831A1 (xx)
NO (1) NO991672L (xx)
NZ (1) NZ335104A (xx)
OA (1) OA11031A (xx)
PA (1) PA8469301A1 (xx)
PE (1) PE20000418A1 (xx)
PL (1) PL332450A1 (xx)
SG (1) SG125880A1 (xx)
SK (1) SK43699A3 (xx)
TN (1) TNSN99052A1 (xx)
TR (1) TR199900755A2 (xx)
TW (1) TW448147B (xx)
UA (1) UA57750C2 (xx)
UY (1) UY25460A1 (xx)
YU (1) YU18199A (xx)
ZA (1) ZA992631B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
RU2326862C2 (ru) * 2003-08-29 2008-06-20 Басф Акциенгезельшафт Способ получения о-замещенных гидроксиламиновых соединений
WO2015094742A1 (en) 2013-12-18 2015-06-25 Brita Lp Filter assembly for filter as you pour filtration
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Ａｌｋ﹘５抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
US6153609A (en) 1996-08-23 2000-11-28 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
BR9807815A (pt) 1997-02-03 2000-03-08 Pfizer Prod Inc Derivados de ácido arilsulfonilamino-hidroxâmico
TR200000368T2 (tr) 1997-08-08 2000-07-21 Pfizer Products Inc. Ariloksiariarilsülfonilamino hidroksamik asit türevleri.
ATE217863T1 (de) 1997-08-08 2002-06-15 Pfizer Prod Inc Arylsulfonylaminohydroxamsäurederivate
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
EA199900284A2 (ru) 1999-10-28
US6288246B1 (en) 2001-09-11
HU9901041D0 (en) 1999-06-28
ID23337A (id) 2000-04-05
HRP990105A2 (en) 2000-02-29
HUP9901041A2 (hu) 2000-03-28
PA8469301A1 (es) 2000-09-29
TW448147B (en) 2001-08-01
NO991672L (no) 1999-10-11
TNSN99052A1 (fr) 2005-11-10
EA199900284A3 (ru) 2000-04-24
MA24831A1 (fr) 1999-12-31
AP1203A (en) 2003-09-05
AU747629B2 (en) 2002-05-16
BR9901089A (pt) 2000-05-30
ZA992631B (en) 2000-10-09
CA2268680A1 (en) 1999-10-10
DZ2757A1 (fr) 2003-09-15
NZ335104A (en) 2000-10-27
IN192342B (xx) 2004-04-10
NO991672D0 (no) 1999-04-09
UA57750C2 (uk) 2003-07-15
EP0949244A2 (en) 1999-10-13
AP9901503A0 (en) 1999-06-30
IL129328A0 (en) 2000-02-17
AU2369099A (en) 1999-10-21
KR100329902B1 (ko) 2002-03-22
TR199900755A3 (tr) 1999-11-22
CO5070713A1 (es) 2001-08-28
UY25460A1 (es) 1999-11-17
BG103319A (en) 2001-08-31
PL332450A1 (en) 1999-10-11
KR19990083051A (ko) 1999-11-25
YU18199A (sh) 2002-11-15
TR199900755A2 (xx) 1999-11-22
CN1232023A (zh) 1999-10-20
BG64154B1 (bg) 2004-02-27
HUP9901041A3 (en) 2003-02-28
JPH11343277A (ja) 1999-12-14
EG22263A (en) 2002-11-30
GT199900046A (es) 2000-09-15
IS5019A (is) 1999-10-11
EA002777B1 (ru) 2002-08-29
AR018180A1 (es) 2001-10-31
SG125880A1 (en) 2006-10-30
PE20000418A1 (es) 2000-05-23
OA11031A (en) 2002-02-07
EP0949244A3 (en) 2001-05-30

Similar Documents

Publication Publication Date Title
NO312665B1 (no) Sulfonerte aminosyrederivater, preparater for inhibering av metalloproteinase inneholdende slike forbindelser, samt anvendelseav slike forbindelser til fremstilling av farmasöytiske preparater
JPS6036461A (ja) 軟骨減成阻止剤およびその製法
SK43699A3 (en) Process for preparing hydroxamic acids
SK45399A3 (en) Process for alkylating hindered sulfonamides
US4100347A (en) 3,4-Dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
US6118016A (en) Process for preparing phenoxyphenylsulfonyl halides
CZ122199A3 (cs) Způsob výroby hydroxamových kyselin
CZ115599A3 (cs) Způsob alkylace bráněných sulfonamidů
KR810000290B1 (ko) 3, 4-디하이드로-2-메틸-4-옥소-2h-1, 2-벤조티아진-3-카복실산-1, 1-디옥사이드의 제조방법
JPH07291965A (ja) 新規なピロリジン誘導体
CZ9901234A3 (cs) Způsoby a meziprodukty pro výrobu fenoxyfenylsulfonylhalogenidů